Yuet Ming Tham is a Partner in Sidley & Austin LLP's Hong Kong office and focuses on cross-border compliance and investigations, and dispute resolution. She advises international corporations on their legal risks across Asia, such as those relating to anti-bribery laws (including the Foreign Corrupt Practices Act), international trade controls, sanctions, anti-money laundering regulations, e-commerce, data security and privacy.
Ms. Tham has worked on numerous investigations involving the U.S. Department of Justice and the Securities and Exchange Commission (SEC). She has also been involved in cases involving the Securities and Futures Commission in Hong Kong, the State Administration of Industry and Commerce (the SAIC) in China, the Fair Trade Commissions in Korea and Taiwan, and issues relating to the Fair Competition Code in Japan. Yuet often conducts compliance risk assessments for her clients’ business operations in Asia, and has set up numerous compliance programs around the world and conducted FCPA due diligence of business partners.
Prior to joining Sidley, Ms. Tham was the Asia Head of the Regulatory, Compliance & Investigations Group, and also Head of the Asia Life Sciences Group at DLA Piper. She has also held roles as a Deputy Public Prosecutor in Singapore and was previously the Asia-Pacific Regional Compliance Director for Pfizer. During that time, she was responsible for compliance and investigations in Japan, China, Australia, Korea, India, Indonesia, Thailand, Taiwan, Hong Kong, Malaysia, Singapore and the Philippines.
Ms. Tham sits on the Advisory Board of Seton-Hall University’s Healthcare Compliance Program for Asia, and a member of the Editorial Board of the Life Sciences Compliance Journal. She is fluent in English, Mandarin, Cantonese and Malay.
Ms. Tham received her LL.B. from Queen Mary, University of London.
She is a co-author of Bloomberg BNA Privacy & Data Security Practice Portfolio Series No. 515, Privacy and Security Issues in Cloud Computing.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to email@example.com.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to firstname.lastname@example.org.
Put me on standing order
Notify me when new releases are available (no standing order will be created)